Western Medicine

Phase 3Small molecule

PPeking Union Medical College Hospital

Western Medicine is one of 151 small molecule programs targeting Obstructive Sleep Apnea. It is currently in Phase 3.

Indications

Total Trials

Active Trials

150

Competitors

Pipeline

Status by Indication[3][1]

Indication

Obstructive Sleep ApneaActive, not recruiting

PsoriasisActive, not recruiting

OsteoarthritisActive, not recruiting

Burning Mouth SyndromeActive, not recruiting

InfertilityActive, not recruiting

Obstructive Sleep ApneaPreclinical

Active, not recruiting

PsoriasisPhase 1

Active, not recruiting

OsteoarthritisPreclinical

Active, not recruiting

Burning Mouth SyndromePhase 3

Active, not recruiting

InfertilityPhase 3

Active, not recruiting

Competition

Competitive Landscape

778 competitors in Osteoarthritis

#DrugCompanyPhaseTrials

Western Medicine

PPeking Union Medical College Hospital

Phase 3

1 2

Epidiolex

Jazz Pharmaceuticals

Preclinical

4 3

Toradol

Roche

Preclinical

1 4

Voltaren

CCerimon Pharmaceuticals

Preclinical

4 5

Glucophage

Boehringer Ingelheim

Preclinical

1 6

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Preclinical

1 7

Protonix

WWyeth-Lederle Vaccines

Preclinical

1 8

Catapres

Boehringer Ingelheim

Preclinical

1 9

MS Contin

HHikma Pharmaceuticals LLC

Preclinical

1 10

Paracetamol

GSK

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q3 2028

Phase 3Not yet recruiting

Infertility

NCT07296614

N/ANot yet recruiting

Osteoarthritis

NCT07072442

Clinical

Trials by Indication[1]

Infertility1 trial

Clinical Evaluation of Integrated Chinese-Western Medicine for Infertility With DOR Patients in Women Achieving Natural Pregnancy

Not yet recruiting·PPeking Union Medical College Hospital·Phase 3·NCT07296614·320 enrolled

Obstructive Sleep Apnea1 trial

Collaborative Care Model for Allergic Rhinitis With Obstructive Sleep Apnea From Prevention to Treatment.

Unknown status·—·N/A·NCT04621513·60 enrolled

Treatment1 trial

Chinese and Western Medicine Treatment of Fever Associated With Bleeding Symptoms

Unknown status·GGuangzhou 8th People's Hospital·Phase 2·NCT01973855·300 enrolled

Osteoarthritis1 trial

Integrative Chinese and Western Medicine for Knee Osteoarthritis

Not yet recruiting·—·N/A·NCT07072442·228 enrolled

Burning Mouth Syndrome1 trial

Treatment of Burning Mouth Syndrome With Integration of Traditional Chinese Medicine and Western Medicine

Unknown status·—·Phase 3·NCT04189367·80 enrolled

1 more indication

Psoriasis1 trial

Comprehensive Intervention of Diabetes and Psoriasis Comorbidity Prevention and Control

Not yet recruiting·SShanghai Yueyang Integrated Medicine Hospital·Phase 1·NCT06402760·300 enrolled

Sources

References

[1]
ClinicalTrials.gov — 6 trial records for Western Medicine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Western Medicine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Western Medicine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Peking Union Medical College Hospital company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 3[1]
Company: PPeking Union Medical College Hospital

Western Medicine

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q3 2028

Trials by Indication[1]

Infertility1 trial

Obstructive Sleep Apnea1 trial

Treatment1 trial

Osteoarthritis1 trial

Burning Mouth Syndrome1 trial

Psoriasis1 trial

References

Drug Info

Quick Facts

Related News